Open label treatment and survival continuation study of atamestane plus toremifene versus letrozole in advanced breast cancer
Phase of Trial: Phase III
Latest Information Update: 07 Dec 2012
At a glance
- Drugs Atamestane; Letrozole; Toremifene
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Intarcia Therapeutics
- 07 Sep 2007 Status change from in progress to discontinued.
- 17 Nov 2006 New trial record.